These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3552720)

  • 21. In vitro studies on anthracycline haloderivatives.
    Facchinetti T; Geroni C; Fumagalli A; Giuliani FC
    Drugs Exp Clin Res; 1986; 12(8):657-61. PubMed ID: 3463498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicin.
    Ando S; Kamiya K; Yoshimura T; Tsutani H; Ueda T; Uchida M; Nakamura T; Uchino H
    Anticancer Res; 1988; 8(3):409-15. PubMed ID: 3164610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1981; 76():21-40. PubMed ID: 6940212
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential resistance to anthracyclines in P-glycoprotein-expressing human hepatoma cells.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):89-92. PubMed ID: 9520154
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis.
    Dartsch DC; Schaefer A; Boldt S; Kolch W; Marquardt H
    Apoptosis; 2002 Dec; 7(6):537-48. PubMed ID: 12370496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular glutathione as a determinant of responsiveness to antitumor drugs.
    Romine MT; Kessel D
    Biochem Pharmacol; 1986 Oct; 35(19):3323-6. PubMed ID: 3464280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity.
    Iwamoto Y; Hansen IL; Porter TH; Folkers K
    Biochem Biophys Res Commun; 1974 Jun; 58(3):633-8. PubMed ID: 4152017
    [No Abstract]   [Full Text] [Related]  

  • 28. Anthracycline antibiotic pharmacology and metabolism.
    Bachur NR
    Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative flavoprotein catalysis of anthracycline antibiotic. Reductive cleavage and oxygen consumption.
    Pan SS; Pedersen L; Bachur NR
    Mol Pharmacol; 1981 Jan; 19(1):184-6. PubMed ID: 6937729
    [No Abstract]   [Full Text] [Related]  

  • 30. [Differentiation of human promyelocytic leukemic cells (HL-60) induced by aclacinomycin-B].
    Lu Y; Han J; Liu HY; Zhong GP; Yang S; Jia TZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):211-3. PubMed ID: 2946461
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on collagenase inhibitors. III. Inhibitory effects of anthracyclines on bacterial collagenase].
    Tanaka T; Metori K; Mineo S; Matsumoto H; Satoh T
    Yakugaku Zasshi; 1991 Jan; 111(1):70-2. PubMed ID: 1647453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.
    Steinheider G; Westendorf J; Marquardt H
    Experientia; 1987 May; 43(5):586-8. PubMed ID: 3472901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
    Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
    Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
    Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
    J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relation between respiration and swelling of liver mitochondria induced by anthracycline antibiotics].
    Suslova AI; Gorskaia IA; Sheveleva ID; Kaverinskaia TV; Tsofina LM
    Biokhimiia; 1988 Feb; 53(2):227-32. PubMed ID: 3163503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD; Bachur NR
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract]   [Full Text] [Related]  

  • 37. A new antitumor antibiotic, carminomycin (NSC-180024).
    Gause GF; Brazhnikova MG; Shorin VA
    Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
    Inaba M; Nagashima K; Sakurai Y; Fukui M; Yanagi Y
    Gan; 1984 Dec; 75(12):1049-52. PubMed ID: 6597118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of anthracyclines with covalently closed circular DNA.
    Mong S; DuVernay VH; Strong JE; Crooke ST
    Mol Pharmacol; 1980 Jan; 17(1):100-4. PubMed ID: 6155600
    [No Abstract]   [Full Text] [Related]  

  • 40. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.